Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Transplantation and Cellular Therapy|January 23, 2023
A Hematopoietic Stem Cell Transplantation Startup in Iraqi Kurdistan: Results in Thalassemia Patients and Analysis of the MethodologyMarta Verna, Marta Canesi, Valentino Conter, et al.Transplantation and Cellular Therapy|December 22, 2021
Do Weekly Surveillance Cultures Contribute to Antibiotic Stewardship and Correlate with Outcome of HSCT in Children? A Multicenter Real-World Experience of 5 Years from the Indian SubcontinentRakesh Dhanya, Rajat Kumar Agarwal, Stalin Ramprakash, et al.Bone Marrow Transplantation|August 31, 2021
Recommendations on hematopoietic stem cell transplantation for patients with Diamond-Blackfan anemia. On behalf of the Pediatric Diseases and Severe Aplastic Anemia Working Parties of the EBMTCristina Diaz-de-Heredia, Dorine Bresters, Lawrence Faulkner, et al.Ejhaem|July 18, 2022
Is it safe and efficacious to remove central lines in pediatric bone marrow transplant patients with platelets less than 20,000/μl?Priya Marwah, Stalin Ramprakash, Sai Prasad T R, et al.Transplantation and Cellular Therapy|July 22, 2023
Bone Marrow Quality Index: A Predictor of Acute Graft-versus-Host Disease in Hematopoietic Stem Cell Transplantation for ThalassemiaRajat Kumar Agarwal, Rakesh Dhanya, Amit Sedai, et al.Transfusion|August 24, 2007
Peripheral blood progenitor uncontrolled-rate freezing: a single pediatric center experienceAlberto Iannalfi, Franco Bambi, Veronica Tintori, et al.Pediatric Transplantation|June 2, 2026
Incidence, Risk Factors, and Outcome of Transplant-Related Intra-Cranial Hemorrhage in Pediatric Thalassemia Major PatientsAliya Batool, Sadaf Khalid, Zholdasbekova Ainur, et al.British Journal of Haematology|August 30, 2025
Short-term risks and benefits of hydroxyurea (hydroxycarbamide)-induced transfusion independence in patients with beta-thalassaemia syndromesB R Sevanthini, Santhosh Hegde, Tejashree Sridhar, et al.Pediatric Blood & Cancer|March 27, 2015
SIOP-PODC adapted risk stratification and treatment guidelines: Recommendations for neuroblastoma in low- and middle-income settingsNehal S Parikh, Scott C Howard, Guillermo Chantada, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2020
Splenomegaly May Increase the Risk of Rejection in Low-Risk Matched Related Donor Transplant for Thalassemia, This Risk Can Be Partially Overcome by Additional Immunosuppression during ConditioningStalin Ramprakash, C P Raghuram, Priya Marwah, et al.Pageof 3